ACCOUNTS - Final Accounts preparation

Analysis of the maturity of loans is given below:

Registered number: 09472238

HITCHIN OSTEOPATHY LIMITED

UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2025

HITCHIN OSTEOPATHY LIMITED

REGISTERED NUMBER: 09472238

STATEMENT OF FINANCIAL POSITION

AS AT 31 MARCH 2025

		2025		2024
Note		£		£

Fixed assets
Tangible assets	4		1,397		696
			1,397		696
Current assets
Debtors: amounts falling due within one year	5	1,048		8,493
Cash at bank and in hand		24,128		17,036
		25,176		25,529
Creditors: amounts falling due within one year	6	(14,540)		(13,620)
Net current assets			10,636		11,909
Total assets less current liabilities			12,033		12,605
Creditors: amounts falling due after more than one year	7		(780)		(3,863)

Net assets			11,253		8,742

Capital and reserves
Called up share capital	9	2	2
Profit and loss account		11,251	8,740
		11,253	8,742

Page 1

HITCHIN OSTEOPATHY LIMITED

REGISTERED NUMBER: 09472238

STATEMENT OF FINANCIAL POSITION (CONTINUED)

AS AT 31 MARCH 2025

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 3 October 2025.

R Kraina

Director

The notes on pages 3 to 8 form part of these financial statements.

Page 2

HITCHIN OSTEOPATHY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

1.Accounting policies

1.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The presentational currency of the Company is GBP.

The following principal accounting policies have been applied:

1.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:

∙the amount of revenue can be measured reliably;

∙it is probable that the Company will receive the consideration due under the contract;

∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and

∙the costs incurred and the costs to complete the contract can be measured reliably.

1.3

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

1.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

1.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

1.6

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

Page 3

HITCHIN OSTEOPATHY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

1.Accounting policies (continued)

1.7

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

1.8

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery	-	33%	straight line
Fixtures and fittings	-	20%	straight line
Office equipment	-	33%	straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

1.9

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

1.10

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

1.11

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 4

HITCHIN OSTEOPATHY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

1.Accounting policies (continued)

1.12

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2.	General information

Hitchin Osteopathy Limited is a private company, limited by shares and incorporated in England
Its registered number is: 09472238
Its Registered Office is:
11 Bridge Street
Hitchin
Hertfordshire
SG5 2DE

Employees

The average monthly number of employees, including directors, during the year was 1 (2024 - 1).

Page 5

HITCHIN OSTEOPATHY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

4.	Tangible fixed assets

	Plant and machinery	Fixtures and fittings	Office equipment	Total
	£	£	£	£
Cost or valuation
At 1 April 2024	210	3,220	11,347	14,777
Additions	-	-	1,579	1,579
Disposals	-	-	(10,197)	(10,197)
At 31 March 2025	210	3,220	2,729	6,159
Depreciation
At 1 April 2024	140	3,096	10,845	14,081
Charge for the year on owned assets	70	31	777	878
Disposals	-	-	(10,197)	(10,197)
At 31 March 2025	210	3,127	1,425	4,762
Net book value
At 31 March 2025	-	93	1,304	1,397
At 31 March 2024	70	124	502	696

Page 6

HITCHIN OSTEOPATHY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

Debtors

					2025	2024
					£	£


Trade debtors	826	7,324
Other debtors	-	840
Prepayments and accrued income	222	329
	1,048	8,493

6.	Creditors: Amounts falling due within one year
		2025	2024
		£	£

Bank loans	3,135	3,105
Trade creditors	494	-
Corporation tax	7,231	8,428
Other creditors	1,850	347
Accruals and deferred income	1,830	1,740
	14,540	13,620

7.	Creditors: Amounts falling due after more than one year
		2025	2024
		£	£

Bank loans	780	3,863
	780	3,863

Page 7

HITCHIN OSTEOPATHY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

Amounts falling due within one year
Bank loans	3,135	3,105
	3,135	3,105
Amounts falling due 1-2 years
Bank loans	780	3,105
	780	3,105
Amounts falling due 2-5 years
Bank loans	-	760
	-	760

	3,915	6,970

9.	Share capital
		2025	2024
		£	£

Allotted, called up and fully paid

1 (2024 - 1) Ordinary share of £1.00	1	1
1 (2024 - 1) Ordinary B share of £1.00	1	1

	2	2

Page 8